PRM
NEUTRALProteome Sciences Provides AGM Business Update
The healthcare services provider reports a rebound in demand for its proteomics offerings, with increased customer orders and services.
Proteome Sciences
3.3600GBX
0.00%
Market Cap
9.92M
Volume
55.14k
25% of avg
P/E Ratio
EPS (TTM)
Beta
-0.01
Day Range
0.0000p - 0.0000p
52 Week Range
0.0000p3.3600p5.4000p
3.3600p
Upcoming Events
2026
Completion of a significant portion of the contract work
High Impact Event
PRM
BADProteome Sciences Reports Increased Losses Amid Challenging Market Conditions
The proteomics firm reported increased annual losses and declining cash reserves, despite a slight uptick in TMT reagent sales. Management cites challenging market conditions but expresses optimism for future recovery.
PRM
NEUTRALProteome Sciences Announces Year-End Results and Investor Presentation
The healthcare company will announce its 2024 results on April 10th and host an investor presentation on April 11th.
PRM
GOODProteome Sciences Secures Substantial US$1m+ Contract
The diagnostics and research company has secured a substantial contract worth over US$1m from a US biopharmaceutical client, with work expected to be completed in the current and next financial years.
PRM
GOODProteome Sciences Secures Loan Facility, Provides Upbeat Trading Update
The healthcare services provider reports strong growth in orders for its proteomics services, with momentum continuing into 2025 and 2026. The company is securing additional financing to expand capacity to meet demand.
PRM
BADProteome Sciences Struggles with Biotech Slowdown, but Sees Potential in New Product Launches
Proteome Sciences, a provider of contract proteomics services, reports a significant decline in revenue and profitability, raising concerns about its financial stability.
PRM
GOODProteome Sciences Poised for Growth in 2024 with New Offerings and Facility
Proteomics services provider Proteome Sciences reports strong customer interest and growth outlook
PRM
GOODProteome Sciences Secures Substantial Contract for Clinical Trial Services
Proteome Sciences secures major contract for clinical trial services
PRM
BADProteome Sciences Reports Challenging Year, Invests for Future Growth
Proteomics specialist reports losses
PRM
GOODProteome Sciences Opens New Lab Facility in San Diego Biotech Hub
Proteome Sciences opens new proteomics lab in San Diego biotech hub to serve growing US customer demand.